HCRN Directory

Head and Neck

A Phase II Hoosier Oncology Group Trial of interferon Alpha-2b (IFN) added to Cisplatin (CDDP) and 5-Fluorouracil (FU) in Recurrent or Metastatic Head and Neck Cancer

Status

Cancer Types

Head and Neck

Locations

A Phase II Trial of Ifosfamide in the Treatment of Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Status

Cancer Types

Head and Neck

Locations

HCRN-HN23-623

A Phase II, Single Arm, Open Label, Multi-center Trial of Neoadjuvant Radiation and Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Previously Untreated Locally Advanced, Resectable, HPV Mediated Oropharynx Cancer

Status

Cancer Types

Head and Neck

Locations

California, Moores Cancer Center at UC San Diego Health, Providence Cancer Institute

BTCRC-HN17-111

Phase II Trial of Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma: Big Ten Cancer Research Consortium BTCRC-HN17-111

Status

Open to Accrual

Cancer Types

Head and Neck

Locations

Masonic Cancer Center, University of Minnesota, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, University of Illinois Cancer Center, University of Iowa Holden Comprehensive Cancer Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Michigan Rogel Cancer Center, University of Wisconsin Carbone Cancer Center

HCRN-HN96-1

A Phase II Trial of Doxil in Advanced or Recurrent Head and Neck Cancer

Status

Closed

Cancer Types

Head and Neck

Locations

HN02-40

A Single Arm Phase II Trial of Docetaxel and Capecitabine for the First Line Treatment of Recurrent/ Metastatic Squamous Cell Carcinoma of the Head and Neck

Status

Closed

Cancer Types

Head and Neck

Locations

HCRN-HN94-1

A Phase II Trial of Ifosfamide in the Treatment of Advanced or Recurrent Squamous Cell Cancer of the Head and Neck

Status

Closed

Cancer Types

Head and Neck

Locations

HCRN-HN90-1

Phase II Trial of Interferon Alpha-2b plus Cisplatin and 5-FU in Recurrent or Metastatic Head and Neck Cancer

Status

Closed

Cancer Types

Head and Neck

Locations